This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Chong Kun Dang Pharmaceutical Corporation, Samsung Life Public Welfare Foundation. Active years: 2016-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 52 
1 out of 145 
Years Active: 2016-2017
Title: Exploring the Innovations of Inventor Yun Tae Kim
Introduction
Yun Tae Kim, an accomplished inventor based in Gyeonggi-do, South Korea, has made significant contributions to the fields of medical research and pharmaceutical science. He holds two patents that showcase his innovative approach to understanding and treating diseases.
Latest Patents
Kim's recent work includes two notable patents. The first patent is titled "Animal model of Charcot-Marie-Tooth disease as HSP27 mutant (S135F) carrier." This invention focuses on a novel animal model that demonstrates the effects of a specific mutation related to Charcot-Marie-Tooth disease. The model, achieved through the injection of a vector in mouse zygotes, effectively replicates the disease phenotype, thereby allowing for the evaluation of candidate treatments.
The second patent is for "Biaryl- or heterocyclic biaryl-substituted cyclohexene derivative compounds as CETP inhibitors." This invention encompasses a class of compounds that can inhibit CETP, a protein that plays a role in cholesterol transport. The compounds have the potential to increase HDL-cholesterol levels while reducing LDL-cholesterol levels, making them valuable for treating dyslipidemia and related conditions.
Career Highlights
Throughout his career, Yun Tae Kim has worked with prominent organizations, including Chong Kun Dang Pharmaceutical Corporation, where he contributed to advancements in pharmaceutical research. Additionally, he was involved with the Samsung Life Public Welfare Foundation, furthering his commitment to enhancing public health through innovation.
Collaborations
Kim has collaborated with various professionals in the field, including Byung-Ok Choi and Sung Chul Jung. These collaborations have allowed him to combine expertise, leading to more effective and innovative solutions in the medical field.
Conclusion
Yun Tae Kim represents a strong example of innovation within the realm of medical research and pharmaceutical development. His patents not only provide insights into genetic conditions but also offer potential therapeutic avenues for treatment. His work continues to impact the scientific community, highlighting the role of inventors in advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile